Affiliations 

  • 1 Physics Department, Faculty of Science, Universiti Teknologi Malaysia (UTM), Skudai-81310, Johor, Malaysia
  • 2 Department of Medical Physics, Institute of Nuclear Medicine and Oncology (INMOL), Lahore, Pakistan
  • 3 Divison of Science and Technology, University of Education, Township Campus, Lahore, Pakistan
  • 4 Center of Excellence in Solid State Physics, University of the Punjab, Lahore, 54590, Pakistan
  • 5 Department of Oncology, Institute of Nuclear Medicine and Oncology (INMOL), Lahore, Pakistan
PLoS One, 2016;11(6):e0158084.
PMID: 27348436 DOI: 10.1371/journal.pone.0158084

Abstract

The current study emphasizes the synthesis of iron oxide nanoparticles (IONPs) and impact of hydrophilic polymer polyvinyl alcohol (PVA) coating concentration as well as anticancer drug doxorubicin (DOX) loading on saturation magnetization for target drug delivery applications. Iron oxide nanoparticles particles were synthesized by a reformed version of the co-precipitation method. The coating of polyvinyl alcohol along with doxorubicin loading was carried out by the physical immobilization method. X-ray diffraction confirmed the magnetite (Fe3O4) structure of particles that remained unchanged before and after polyvinyl alcohol coating and drug loading. Microstructure and morphological analysis was carried out by transmission electron microscopy revealing the formation of nanoparticles with an average size of 10 nm with slight variation after coating and drug loading. Transmission electron microscopy, energy dispersive, and Fourier transform infrared spectra further confirmed the conjugation of polymer and doxorubicin with iron oxide nanoparticles. The room temperature superparamagnetic behavior of polymer-coated and drug-loaded magnetite nanoparticles were studied by vibrating sample magnetometer. The variation in saturation magnetization after coating evaluated that a sufficient amount of polyvinyl alcohol would be 3 wt. % regarding the externally controlled movement of IONPs in blood under the influence of applied magnetic field for in-vivo target drug delivery.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.